Oral MCS - Complications Bleeding/Thrombosis

160 - Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device

Presentation Number
160
Presenter
Co-Authors

Previous Eposter
108 - Variability of Both Raw and Transformed Gene Expression Profile Scores Predict Adverse Events Post Heart Transplant: The Mid America Experience

Next Eposters
487 - Repeated, Planned Levosimendan Infusions in Patients With Advanced Heart Failure Eligible for Heart Transplantation
366 - Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial Hypertension
187 - Leukocytes from Lung Transplant Recipients with Severe Primary Graft Dysfunction Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo
377 - Survival and Outcome in Pediatric Myocarditis - 3 Year Data from the German Multi-center Prospective Myocarditis Registry: “MYKKE”
115 - Abnormal Invasive Pulmonary Hemodynamics Predict Outcomes in Exercising Patients
387 - Ticagrelor but not Aspirin Limits Shear-Mediated Platelet Activation
389 - MCS Shear-Medicated Platelet Activation Does not Cause Integrin GPIIbIIIa Activation, Rather Shedding and Microparticle Generation
138 - Mycophenolic Acid Trough Levels Underestimate Drug Exposure in Pediatric Heart Transplant Patients
338 - Right Ventricular Remodeling in Chronic Thrombo-Embolic Pulmonary Hypertension
385 - SSRI/SNRI Therapy is Associated with a Higher Risk of GI Bleed in LVAD Patients